304 related articles for article (PubMed ID: 26357785)
1. Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.
Landis RC; Brown JR; Fitzgerald D; Likosky DS; Shore-Lesserson L; Baker RA; Hammon JW
J Extra Corpor Technol; 2014 Sep; 46(3):197-211. PubMed ID: 26357785
[TBL] [Abstract][Full Text] [Related]
2. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population.
Durandy Y
Artif Organs; 2014 Jan; 38(1):11-8. PubMed ID: 24392866
[TBL] [Abstract][Full Text] [Related]
3. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery.
Kilger E; Weis F; Briegel J; Frey L; Goetz AE; Reuter D; Nagy A; Schuetz A; Lamm P; Knoll A; Peter K
Crit Care Med; 2003 Apr; 31(4):1068-74. PubMed ID: 12682474
[TBL] [Abstract][Full Text] [Related]
4. Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review.
Morgan C; Zappitelli M; Gill P
Crit Care; 2009; 13(5):R165. PubMed ID: 19840397
[TBL] [Abstract][Full Text] [Related]
5. Modulation of systemic inflammatory response after cardiac surgery.
Raja SG; Dreyfus GD
Asian Cardiovasc Thorac Ann; 2005 Dec; 13(4):382-95. PubMed ID: 16304234
[TBL] [Abstract][Full Text] [Related]
6. Systemic leukofiltration does not attenuate pulmonary injury after cardiopulmonary bypass.
Warren OJ; Tunnicliffe CR; Massey RM; Wallace S; Smith AJ; Alcock EM; Darzi A; Vincent CA; Athanasiou T
ASAIO J; 2008; 54(1):78-88. PubMed ID: 18204320
[TBL] [Abstract][Full Text] [Related]
7. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis.
Ho KM; Tan JA
Circulation; 2009 Apr; 119(14):1853-66. PubMed ID: 19332460
[TBL] [Abstract][Full Text] [Related]
8. eComment: Re: The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Bockeria LA; Grigoryants RG
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):99. PubMed ID: 19122158
[No Abstract] [Full Text] [Related]
9. Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome?
Sobieski MA; Graham JD; Pappas PS; Tatooles AJ; Slaughter MS
ASAIO J; 2008; 54(2):203-6. PubMed ID: 18356656
[TBL] [Abstract][Full Text] [Related]
10. In-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care Patients.
Sasse M; Dziuba F; Jack T; Köditz H; Kaussen T; Bertram H; Beerbaum P; Boehne M
Pediatr Cardiol; 2015 Aug; 36(6):1270-8. PubMed ID: 25845941
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial.
James C; Millar J; Horton S; Brizard C; Molesworth C; Butt W
Intensive Care Med; 2016 Nov; 42(11):1744-1752. PubMed ID: 27686343
[TBL] [Abstract][Full Text] [Related]
12. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass.
Treacher DF; Sabbato M; Brown KA; Gant V
Perfusion; 2001 Mar; 16 Suppl():67-73. PubMed ID: 11334210
[TBL] [Abstract][Full Text] [Related]
13. [Inflammatory response and haematological disorders in cardiac surgery: toward a more physiological cardiopulmonary bypass].
Baufreton C; Corbeau JJ; Pinaud F
Ann Fr Anesth Reanim; 2006 May; 25(5):510-20. PubMed ID: 16488106
[TBL] [Abstract][Full Text] [Related]
14. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
15. Heparin-coated cardiopulmonary bypass circuits: current status.
Hsu LC
Perfusion; 2001 Sep; 16(5):417-28. PubMed ID: 11565897
[TBL] [Abstract][Full Text] [Related]
16. Deleterious effects of cardiopulmonary bypass in coronary artery surgery and scientific interpretation of off-pump's logic.
Elahi MM; Khan JS; Matata BM
Acute Card Care; 2006; 8(4):196-209. PubMed ID: 17162546
[TBL] [Abstract][Full Text] [Related]
17. Low preoperative cholesterol level is a risk factor of sepsis and poor clinical outcome in patients undergoing cardiac surgery with cardiopulmonary bypass.
Lagrost L; Girard C; Grosjean S; Masson D; Deckert V; Gautier T; Debomy F; Vinault S; Jeannin A; Labbé J; Bonithon-Kopp C
Crit Care Med; 2014 May; 42(5):1065-73. PubMed ID: 24413578
[TBL] [Abstract][Full Text] [Related]
18. Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass?
Chew MS
Perfusion; 2004; 19 Suppl 1():S57-60. PubMed ID: 15161065
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection.
Olivencia-Yurvati AH; Wallace N; Ford S; Mallet RT
Perfusion; 2004; 19 Suppl 1():S13-9. PubMed ID: 15161060
[TBL] [Abstract][Full Text] [Related]
20. The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: a randomized trial.
Stocker CF; Shekerdemian LS; Horton SB; Lee KJ; Eyres R; D'Udekem Y; Brizard CP
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):174-80. PubMed ID: 21420106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
